{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:16:18Z","timestamp":1779333378336,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.neurol.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T21:43:52Z","timestamp":1535233432000},"page":"608-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dystonia: Are animal models relevant in therapeutics?"],"prefix":"10.1016","volume":"174","author":[{"given":"M.","family":"Meringolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Imbriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ponterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.neurol.2018.07.003_bib0325","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-1331.2010.03053.x","article-title":"The epidemiology of primary dystonia: current evidence and perspectives","volume":"17","author":"Defazio","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2018.07.003_bib0330","article-title":"The environmental epidemiology of primary dystonia","volume":"3","author":"Defazio","year":"2013","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"issue":"Suppl 1","key":"10.1016\/j.neurol.2018.07.003_bib0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0733-8619(08)80002-3","article-title":"Cervical dystonia: etiology and pathophysiology","volume":"26","author":"Singer","year":"2008","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neurol.2018.07.003_bib0340","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.07.003_bib0345","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pneurobio.2008.10.003","article-title":"Primate models of dystonia","volume":"87","author":"Guehl","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurol.2018.07.003_bib0350","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mds.25536","article-title":"Genetics of dystonia: what's known? what's new? what's next?","volume":"28","author":"Lohmann","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.07.003_bib0355","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11910-013-0410-z","article-title":"Genetics in dystonia: an update","volume":"13","author":"Fuchs","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.neurol.2018.07.003_bib0360","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/brain\/awt138","article-title":"The genetics of dystonia: new twists in an old tale","volume":"136","author":"Charlesworth","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.07.003_bib0365","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2152\/jmi.52.272","article-title":"Neuroimaging in human dystonia","volume":"52 Suppl","author":"Asanuma","year":"2005","journal-title":"J Med Invest"},{"key":"10.1016\/j.neurol.2018.07.003_bib0370","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mds.25527","article-title":"The anatomical basis of dystonia: current view using neuroimaging","volume":"28","author":"Leh\u00e9ricy","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.07.003_bib0375","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/mds.27123","article-title":"It's not just the basal ganglia: cerebellum as a target for dystonia therapeutics","volume":"32","author":"Tewari","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.07.003_bib0380","first-page":"1024","article-title":"In vitro test systems and their limitations","volume":"12","author":"Ghallab","year":"2013","journal-title":"EXCLI J"},{"key":"10.1016\/j.neurol.2018.07.003_bib0385","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/biot.201000183","article-title":"Modeling human diseases in Caenorhabditis elegans","volume":"5","author":"Markaki","year":"2010","journal-title":"Biotechnol J"},{"key":"10.1016\/j.neurol.2018.07.003_bib0390","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.110.003293","article-title":"Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery","volume":"63","author":"Pandey","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neurol.2018.07.003_bib0395","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0684.1997.tb00042.x","article-title":"Advantages and limitations of non-human primates as animal models in genetic research on complex diseases","volume":"26","author":"VandeBerg","year":"1997","journal-title":"J Med Primatol"},{"key":"10.1016\/j.neurol.2018.07.003_bib0400","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0975-7406.124301","article-title":"Use of rodents as models of human diseases","volume":"6","author":"Vandamme","year":"2014","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.neurol.2018.07.003_bib0405","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/mds.25526","article-title":"Animal models for dystonia","volume":"28","author":"Wilson","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.07.003_bib0410","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrneurol.2009.160","article-title":"Primary dystonia: molecules and mechanisms","volume":"5","author":"Tanabe","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2018.07.003_bib0415","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuron.2005.11.010","article-title":"Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope","volume":"48","author":"Goodchild","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2018.07.003_bib0420","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.devcel.2016.06.017","article-title":"Torsins are essential regulators of cellular lipid metabolism","volume":"38","author":"Grillet","year":"2016","journal-title":"Dev Cell"},{"key":"10.1016\/j.neurol.2018.07.003_bib0425","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.expneurol.2005.08.025","article-title":"Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia","volume":"196","author":"Dang","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2018.07.003_bib0430","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bbr.2011.10.002","article-title":"An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 \u0394GAG knock-in mice","volume":"226","author":"Dang","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neurol.2018.07.003_bib0435","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2012.05.009","article-title":"Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia","volume":"48","author":"Song","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2018.07.003_bib0440","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nbd.2014.01.016","article-title":"Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia","volume":"65","author":"Martella","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2018.07.003_bib0445","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1073\/pnas.1016445108","article-title":"Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice","volume":"108","author":"Ulu\u011f","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2018.07.003_bib0450","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jb\/mvm191","article-title":"Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice","volume":"143","author":"Yokoi","year":"2008","journal-title":"J Biochem"},{"key":"10.1016\/j.neurol.2018.07.003_bib0455","doi-asserted-by":"crossref","first-page":"e24539","DOI":"10.1371\/journal.pone.0024539","article-title":"Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice","volume":"6","author":"Yokoi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurol.2018.07.003_bib0460","doi-asserted-by":"crossref","first-page":"e08352","DOI":"10.7554\/eLife.08352","article-title":"Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons","volume":"4","author":"Pappas","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.neurol.2018.07.003_bib0465","doi-asserted-by":"crossref","first-page":"11991","DOI":"10.1523\/JNEUROSCI.0041-12.2012","article-title":"Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia","volume":"32","author":"Sciamanna","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2018.07.003_bib0470","first-page":"769","article-title":"Dopa-responsive dystonia","volume":"46","author":"Furukawa","year":"2006","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.neurol.2018.07.003_bib0475","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/brain\/awv212","article-title":"A new knock-in mouse model of l-DOPA-responsive dystonia","volume":"138","author":"Rose","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.07.003_bib0480","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbr.2010.09.009","article-title":"Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism","volume":"216","author":"DeAndrade","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neurol.2018.07.003_bib0485","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0306-4522(98)00518-1","article-title":"An ultrastructural study of granule cell\/Purkinje cell synapses in tottering (tg\/tg), leaner (tg(la)\/tg(la)) and compound heterozygous tottering\/leaner (tg\/tg(la)) mice","volume":"90","author":"Rhyu","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurol.2018.07.003_bib0490","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0361-9230(94)00207-H","article-title":"Cerebellar volume decreases in the tottering mouse are specific to the molecular layer","volume":"36","author":"Isaacs","year":"1995","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurol.2018.07.003_bib0495","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1602\/neurorx.2.3.504","article-title":"Animal models of generalized dystonia","volume":"2","author":"Raike","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neurol.2018.07.003_bib0500","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/brain\/awn168","article-title":"The basal ganglia and cerebellum interact in the expression of dystonic movement","volume":"131","author":"Neychev","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2018.07.003_bib0505","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nn.2753","article-title":"The neural substrates of rapid-onset Dystonia-Parkinsonism","volume":"14","author":"Calderon","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurol.2018.07.003_bib0510","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1523\/JNEUROSCI.1409-14.2014","article-title":"Abnormal high-frequency burst firing of cerebellar neurons in rapid-onset dystonia-parkinsonism","volume":"34","author":"Fremont","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2018.07.003_bib0515","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(00)02744-X","article-title":"A di-synaptic projection from the lateral cerebellar nucleus to the laterodorsal part of the striatum via the central lateral nucleus of the thalamus in the rat","volume":"880","author":"Ichinohe","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2018.07.003_bib0520","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nurt.2008.01.001","article-title":"Experimental therapeutics for dystonia","volume":"5","author":"Jinnah","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurol.2018.07.003_bib0525","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14656560903426171","article-title":"Treatment strategies for dystonia","volume":"11","author":"Cloud","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.neurol.2018.07.003_bib0530","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fncel.2013.00055","article-title":"Cholinergic connectivity: it's implications for psychiatric disorders","volume":"7","author":"Scarr","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.neurol.2018.07.003_bib0535","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnsyn.2014.00022","article-title":"Striatal cholinergic interneuron regulation and circuit effects","volume":"6","author":"Lim","year":"2014","journal-title":"Front Synaptic Neurosci"},{"key":"10.1016\/j.neurol.2018.07.003_bib0540","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnana.2011.00006","article-title":"Centrality of striatal cholinergic transmission in Basal Ganglia function","volume":"5","author":"Bonsi","year":"2011","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.neurol.2018.07.003_bib0545","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurol.2018.07.003_bib0550","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pneurobio.2015.02.002","article-title":"Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia","volume":"127","author":"Eskow Jaunarajs","year":"2015","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurol.2018.07.003_bib0555","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ana.10610","article-title":"Impaired sequence learning in carriers of the DYT1 dystonia mutation","volume":"54","author":"Ghilardi","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.07.003_bib0560","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nbd.2010.12.011","article-title":"Abnormal plasticity in dystonia: disruption of synaptic homeostasis","volume":"42","author":"Quartarone","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2018.07.003_bib0565","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/mds.26009","article-title":"Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors","volume":"29","author":"Maltese","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2018.07.003_bib0570","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nbd.2006.07.006","article-title":"Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia","volume":"24","author":"Pisani","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2018.07.003_bib0575","doi-asserted-by":"crossref","first-page":"e24261","DOI":"10.1371\/journal.pone.0024261","article-title":"Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia","volume":"6","author":"Sciamanna","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurol.2018.07.003_bib0580","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuropharm.2014.06.013","article-title":"Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia","volume":"85","author":"Sciamanna","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurol.2018.07.003_bib0585","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(05)63142-X","article-title":"Treatment of spastic dystonia with transdermal nicotine","volume":"350","author":"Vaughan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2018.07.003_bib0590","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0306-4522(84)90058-7","article-title":"Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis","volume":"12","author":"Chesselet","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurol.2018.07.003_bib0595","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2016.03.037","article-title":"Differential dopaminergic regulation of inwardly rectifying potassium channel mediated subthreshold dynamics in striatal medium spiny neurons","volume":"107","author":"Zhao","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurol.2018.07.003_bib0600","doi-asserted-by":"crossref","first-page":"10502","DOI":"10.1523\/JNEUROSCI.3016-05.2005","article-title":"Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia","volume":"25","author":"Gonzalez-Alegre","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2018.07.003_bib0605","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/hmg\/ddn032","article-title":"siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells","volume":"17","author":"Hewett","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2018.07.003_bib0610","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.10548","article-title":"Toward therapy for DYT1 dystonia: allele-specific silencing of mutant torsinA","volume":"53","author":"Gonzalez-Alegre","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2018.07.003_bib0615","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/gt.2011.10","article-title":"Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design","volume":"18","author":"Martin","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.neurol.2018.07.003_bib0620","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s13311-013-0183-8","article-title":"Recent advances in RNA interference therapeutics for CNS diseases","volume":"10","author":"Ramachandran","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurol.2018.07.003_bib0625","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/s41598-018-19865-2","article-title":"Mutant torsinA in the heterozygous DYT1 state compromises HSV propagation in infected neurons and fibroblasts","volume":"8","author":"Gy\u00f6rgy","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurol.2018.07.003_bib0630","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev-pharmtox-010814-124803","article-title":"DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility","volume":"55","author":"Urban","year":"2015","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neurol.2018.07.003_bib0635","doi-asserted-by":"crossref","DOI":"10.1177\/1179069517703354","article-title":"Optogenetic modulation of intracellular signalling and transcription: focus on neuronal plasticity","volume":"11","author":"Eleftheriou","year":"2017","journal-title":"J Exp Neurosci"},{"key":"10.1016\/j.neurol.2018.07.003_bib0640","first-page":"362","article-title":"Advanced in vivo use of CRISPR\/Cas9 and anti-sense DNA inhibition for gene manipulation in the brain","volume":"6","author":"Walters","year":"2015","journal-title":"Front Genet"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378718306623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378718306623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T05:34:01Z","timestamp":1540013641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378718306623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0035378718306623"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2018.07.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dystonia: Are animal models relevant in therapeutics?","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}